Cambridge Bioscience is pleased to announce a new partnership with Aopia Biosciences, a leader in automated extracellular vesicle (EV) isolation technologies. This collaboration will make Aopia’s NanoEX™ platform available to researchers across the UK and Ireland.
The NanoEX™ Automated Bio-nanoparticle Isolation Platform offers high-yield, high-purity isolation of EVs within a closed, fully automated system. It supports reproducible, contamination-free processing with minimal hands-on time.
Through this partnership, Cambridge Bioscience aims to support scientists working in EV research, RNA delivery, and therapeutic research by providing access to Aopia’s tools and expert support.
Published
01 Jul 2025